Sumeet Gujral - Concepedia

Author

Sumeet Gujral

Also Known As

Akash Pawar, Gujral S, Gujral Sumeet, Gujral, Sumeet, Pradip K Majumder, Prashant R. Tembhare, Prathibha Amare, S Gujral, S. Gujral, Sumeet Gujral

309

Publications

9.6K

Citations

H-Index

Concepts

All Affiliations

Tata Memorial Hospital Advanced Centre for Treatment, Research and Education in Cancer Homi Bhabha National Institute All India Institute of Medical Sciences HCG Cancer Hospital

About

Sumeet Gujral is an author at Tata Memorial Hospital specializing in medicine, pathology, and histopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	20	366
2	Health Sciences	6	6	94
3	Allergy	1	1	21
4	Biostatistics	1	1	12
5	Blood Transplantation	1	1	33

Sumeet Gujral

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Primary diffuse large B‐cell lymphoma of the tonsil Siddhartha Laskar, Gaurav Bahl, Mary Ann Muckaden, Cancer	2007	94
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML) Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh, Leukemia	2021	92
Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma Robert Carr, Stefano Fanti, Diana Páez, Journal of Nuclear Medicine	2014	76
A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐10<sup>6</sup>and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients Prashant Tembhare, Papagudi Ganesan Subramanian, Sitaram Ghogale, Cytometry Part B Clinical Cytometry	2019	74
Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma Juliano J. Cerci, Tamás Györke, Stefano Fanti, Journal of Nuclear Medicine	2014	71
Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000–000 Prashant Tembhare, Sitaram Ghogale, Nisha Ghatwai, Cytometry Part B Clinical Cytometry	2016	63
Minimum diagnostic criteria for plasmablastic lymphoma of oral/sinonasal region encountered in a tertiary cancer hospital of a developing country Shubhada Kane, Aditi Khurana, Gorakh Parulkar, Journal of Oral Pathology and Medicine	2008	55
Desmoplastic small round cell tumor: Extra abdominal and abdominal presentations and the results of treatment C. N. Nair, G Biswas, Siddharth Laskar, Indian Journal of Cancer	2005	45
Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis Partha Roy, Shiji John, Sadashiv Karankal, Indian Journal of Medical and Paediatric Oncology	2013	41
A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides Uday Khopkar, Bhavana Doshi, AtulM Dongre, Indian Journal of Dermatology Venereology and Leprology	2011	41

Page 1